- Home
- IMNM vs TR Comparison
IMNM vs TR Comparison
Compare IMNM & TR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMNM | TR |
|---|---|---|
| Founded | 2006 | 1896 |
| Country | United States | United States |
| Employees | N/A | 2300 |
| Industry | Medicinal Chemicals and Botanical Products | Specialty Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.2B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | IMNM | TR |
|---|---|---|
| Price | $20.57 | $41.96 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $32.80 | N/A |
| AVG Volume (30 Days) | ★ 906.1K | 121.3K |
| Earning Date | 03-03-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.86% |
| EPS Growth | ★ 51.40 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,941,000.00 | N/A |
| Revenue This Year | $18.41 | N/A |
| Revenue Next Year | $863.23 | N/A |
| P/E Ratio | ★ N/A | $32.36 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.15 | $29.13 |
| 52 Week High | $27.65 | $44.27 |
Technical Indicators
Market Signals| Indicator | IMNM | TR |
|---|---|---|
| Relative Strength Index (RSI) | 41.75 | 53.49 |
| Support Level | $18.98 | $41.55 |
| Resistance Level | $22.57 | $43.36 |
| Average True Range (ATR) | 1.10 | 1.34 |
| MACD | -0.07 | -0.15 |
| Stochastic Oscillator | 25.75 | 46.76 |
Price Performance
Historical ComparisonAbout IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About TR Tootsie Roll Industries Inc.
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.